11 research outputs found

    Acacia sieberiana Effects on Soil Properties and Plant Diversity in Songa Pastures, Rwanda

    No full text
    Effects of A. sieberiana trees on soil properties and plant diversity were investigated in Songa pastures, Rwanda. Tree characteristics and crown architecture of A. sieberiana were studied. Soil properties were assessed and plants were identified under and away from tree crowns. Counts of individual plants/species were done only under tree crowns. Nitrogen, P, and K were analysed in the soil, grass, and A. sieberiana leaves. Plant diversity was determined using Simpson's diversity index. Data were subjected to ANOVA. Soil organic carbon (SOC), cation exchange capacity (CEC), Ca2+, N and pH, and plant diversity were higher in soils under tree canopies than in open areas. Tree leaves were significantly richer in N and poorer in P and K as compared to grasses. Tree crowns grew wider and horizontal and developed intertwined secondary branching, reducing light intensity to as low as 38% under tree canopies compared to the open pasture. At 3 trees/ha stocking, A. sieberiana trees shaded 0.18 ha and herbaceous plants and grasses unpalatable to livestock dominated under tree canopies. A tradeoff of A. sieberiana tree value versus the loss of palatable grass due to tree presence needs to be assessed to decide whether the trees should be included in pastures and if yes, the apporpriate stocking identified

    Cost of providing quality cancer care at the Butaro Cancer Center of Excellence in Rwanda

    No full text
    Purpose The cost of providing cancer care in low-income countries remains largely unknown, which creates a significant barrier to effective planning and resource allocation. This study examines the cost of providing comprehensive cancer care at the Butaro Cancer Center of Excellence (BCCOE) in Rwanda. Methods A retrospective costing analysis was conducted from the provider perspective by using secondary data from the administrative systems of the BCCOE. We identified the start-up funds necessary to begin initial implementation and determined the fiscal year 2013-2014 operating cost of the cancer program, including capital expenditures and fixed and variable costs. Results A total of $556,105 US dollars was assessed as necessary start-up funding to implement the program. The annual operating cost of the cancer program was found to be $957,203 US dollars. Radiotherapy, labor, and chemotherapy were the most significant cost drivers. Radiotherapy services, which require sending patients out of country because there are no radiation units in Rwanda, comprised 25% of program costs, labor accounted for 21%, and chemotherapy, supportive medications, and consumables accounted for 15%. Overhead, training, computed tomography scans, surgeries, blood products, pathology, and social services accounted for less than 10% of the total. Conclusion This study is one of the first to examine operating costs for implementing a cancer center in a low-income country. Having a strong commitment to cancer care, adapting clinical protocols to the local setting, shifting tasks, and creating collaborative partnerships make it possible for BCCOE to provide quality cancer care at a fraction of the cost seen in middle- and high-income countries, which has saved many lives and improved survival. Not all therapies, though, were available because of limited financial resources

    Cost of treating pediatric cancer at the Butaro Cancer Center of Excellence in Rwanda

    No full text
    Purpose Improvements in childhood survival rates have been achieved in low- and middle- income countries that have made a commitment to improve access to cancer care. Accurate data on the costs of delivering cancer treatment in these settings will allow ministries of health and donors to accurately assess and plan for expansions of access to care. This study assessed the financial cost of treating two common pediatric cancers, nephroblastoma and Hodgkin lymphoma, at the Butaro Cancer Center of Excellence in rural Rwanda. Methods A microcosting approach was used to calculate the per-patient cost for Hodgkin lymphoma and nephroblastoma diagnosis and treatment. Costs were analyzed retrospectively from the provider perspective for the 2014 fiscal year. The cost per patient was determined using an idealized patient receiving a full course of treatment, follow-up, and recommended social support in accordance with the national treatment protocol for each cancer. Results The cost for a full course of treatment, follow-up, and social support was determined to be between $1,490 and $2,093 for a patient with nephroblastoma and between $1,140 and $1,793 for a pediatric patient with Hodgkin lymphoma. Conclusion Task shifting, reduced labor costs, and locally adapted protocols contributed to significantly lower costs than those seen in middle- or high-income countries

    New insights into the indigenous knowledge of the uses of the common stinging nettle (Urtica massaica Mildbr.) in Rwanda

    No full text
    AbstractThe common stinging nettle (Urtica massaica Mildbr., ‘Igisura’) is one of the popular plants used for multiple purposes in Rwanda. This study aimed to get more insights into indigenous knowledge of the multiple uses of this plant in Rwanda. It was conducted in eleven administrative districts in September 2021. A semi-structured questionnaire was used to conduct in-depth interviews with 124 respondents who were chosen using the snowball sampling technique from locations where the stinging nettle grows or has been domesticated. In addition to face-to-face interviews, personal observations, and group discussions were organized at visited sites. Data were analyzed using SPSS. The uses of the common stinging nettle plant can be grouped into five categories: 1. Human medicine, 2. Veterinary medicine, 3. Human nutrition, 4. Animal feeding, and 5. Others. The stinging nettle is used in the form of cooked leaves (47%), leaf powder (39%), boiled leaves (8%), decoction (4%), infusion (1%), and fibers (1%). Stomach ulcers (37%) and hypertension (15%) are the most predominant diseases treated by stinging nettle products. Nearly all respondents (98%) agreed that domesticating the stinging nettle was important and indicated that they would be ready to grow it if they were assured of the market. Nettle products are widely sought to improve the health and well-being of both humans and animals. Yet, they are still scarce on the market. Hence, there is a need to promote the domestication of stinging nettle to increase its production and availability

    New insights into the indigenous knowledge of the uses of the common stinging nettle (<i>Urtica massaica</i> Mildbr.) in Rwanda

    No full text
    The common stinging nettle (Urtica massaica Mildbr., ‘Igisura’) is one of the popular plants used for multiple purposes in Rwanda. This study aimed to get more insights into indigenous knowledge of the multiple uses of this plant in Rwanda. It was conducted in eleven administrative districts in September 2021. A semi-structured questionnaire was used to conduct in-depth interviews with 124 respondents who were chosen using the snowball sampling technique from locations where the stinging nettle grows or has been domesticated. In addition to face-to-face interviews, personal observations, and group discussions were organized at visited sites. Data were analyzed using SPSS. The uses of the common stinging nettle plant can be grouped into five categories: 1. Human medicine, 2. Veterinary medicine, 3. Human nutrition, 4. Animal feeding, and 5. Others. The stinging nettle is used in the form of cooked leaves (47%), leaf powder (39%), boiled leaves (8%), decoction (4%), infusion (1%), and fibers (1%). Stomach ulcers (37%) and hypertension (15%) are the most predominant diseases treated by stinging nettle products. Nearly all respondents (98%) agreed that domesticating the stinging nettle was important and indicated that they would be ready to grow it if they were assured of the market. Nettle products are widely sought to improve the health and well-being of both humans and animals. Yet, they are still scarce on the market. Hence, there is a need to promote the domestication of stinging nettle to increase its production and availability.</p
    corecore